Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.62 USD | -0.69% | -4.74% | +574.12% |
04-05 | Elevation Oncology, Inc. Announces Management Changes | CI |
03-27 | Merrimack Gets $225 Million Milestone Payment, Schedules Meeting For Dissolution Plan | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 198M 270M |
---|---|---|---|---|---|
Net income 2024 * | -45M -61.34M | Net income 2025 * | -59M -80.42M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.24
x | P/E ratio 2025 * |
-4.08
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.95% |
1 day | -0.69% | ||
1 week | -4.74% | ||
Current month | -29.43% | ||
1 month | -29.43% | ||
3 months | +31.16% | ||
6 months | +571.61% | ||
Current year | +574.12% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Ferra
CEO | Chief Executive Officer | 49 | 21-06-16 |
Tammy Furlong
DFI | Director of Finance/CFO | - | - |
Steven Elms
CHM | Chairman | 60 | 19-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Carruthers
BRD | Director/Board Member | 66 | 21-05-17 |
Timothy Clackson
BRD | Director/Board Member | 58 | 20-04-30 |
Steven Elms
CHM | Chairman | 60 | 19-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3.62 | -0.69% | 872,578 |
24-04-25 | 3.645 | -6.06% | 1,231,239 |
24-04-24 | 3.88 | -10.19% | 658,115 |
24-04-23 | 4.32 | +6.67% | 327,435 |
24-04-22 | 4.05 | +6.58% | 500,444 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+574.12% | 198M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ELEV Stock